Laboratory Services Act Decisions

The table below reflects changes associated with laboratory tests in BC. For a list of facility changes, please scroll to the second table.

2016 - Laboratory Test Updates

Laboratory Test, Records of Decision under the Laboratory Services Act

LSA ROD #

Approvals Granted

LSA2016-026

Addition of new fee item for Fentanyl, urine screening immunoassay, and amendment to existing Fentanyl confirmatory fee item.

Effective March 1, 2017, the Ministry of Health has approved the addition of a new fee item 92518 Fentanyl, urine screening by immunoassay. The cost per test will be $13.10.   

The Fentanyl confirmatory fee item 92525 was amended by adding a new note to the Laboratory Services Outpatient Payment Schedule that it can only be performed and payable following consultation with and approval by a laboratory medicine physician.
LSA2016-027

Re-costing of B-type natriuretic peptide and addition of the fee item to the primary and split base fee list.

Effective April 1, 2017, the Ministry of Health has amended the fee amount payable for B-type natriuretic peptide (BNP) to $28.14 from $42.56 and made BNP eligible to be co-billed with the primary base fee and split base fees.
LSA2016-018

Establishing non-invasive prenatal testing (NIPT) as an insured benefit in British Columbia

Effective October 9, 2015, NIPT was approved as an insured benefit in British Columbia for pregnant women found to have a significant risk of trisomy by meeting one of the following criteria:

  • Having received a positive prenatal screen for trisomy 18 or 21;
  • Having had previous trisomy 13, 18, or 21 pregnancy;
  • Having a risk of Down Syndrome greater than 1 in 300 based on results of screening and ultrasound marker(s) of aneuploidy; or
  • Having a risk for X-linked disorders identified through the Provincial Medical Genetics program.
LSA2016-031

Request to defer delisting of aspartate aminotransferase (AST) in community outpatient setting.

Effective December 21, 2016, the Ministry of Health is deferring the delisting of aspartate aminotransferase in the community outpatient setting, which was scheduled for February 1, 2017.
LSA2016-021

Request for Cytogenetic Microarray Analysis (CMA) to be funded through fee-for-service.

Cytogenetic Microarray Analysis (CMA) will not be funded on a fee-for-service basis.  
LSA2016-019

Removal of provisional (P) status for Sex Hormone Binding Globulin (SHBG).

Effective September 30, 2016, the P status for fee item 92267 – SHBG was removed.

LSA2016-020

Removal of provisional (P) status for Fecal Immunochemical Test for analysis and Fecal Immunochemical Test for collection.

Effective September 30, 2016, the P status for fee items 92006 and 92007 – FIT was removed.

LSA2016-024

Removal of provisional (P) status for Bile Acids, total – 91241, amendment to the fee amount, and addition of a billing note.

Effective December 1, 2016, the P status for fee item 91241 – Bile Acids, total will be removed, the fee amount will be amended to $36.58 from $55.00, and a billing note will be added that reads “billing restricted to pregnant females only”.

LSA2016-022

Approval of the updated Laboratory Services Payment Schedule - Schedule of Fees

Effective October 1, 2016, the updated Laboratory Services Payment Schedule - Schedule of Fees, was approved.

LSA2016-006

Serum tryptase testing to be repatriated

Serum tryptase testing will no longer be referred out of province. When ready, BC Women’s and Children’s Hospital will provide the testing. Outpatient testing is restricted to physician specialists who are investigating follow-up anaphylaxis, mastocytosis, and mast cell activation disorders. Conversely, inpatient requests are not restricted as testing is almost always clinically indicated.

LSA2016-007

120 inactive outpatient tests to be cancelled, and addition of billing notes

Effective June 30, 2016, 105 Chemistry and 15 Hematology fee-for-service outpatient tests were delisted as they were inactive or had been replaced by other tests. For a complete list of the tests, see attachment “120 tests to be removed from the fee-for-service laboratory outpatient payment schedule.” (PDF, 200KB)

Further, a billing note was added to fee item 91770 (hexosaminidases) that reads “Restricted to BC Children’s Hospital only”.

LSA2016-008

Removal of Provisional (P) status for purine, pyrimidine and creatine disorder (PPCD) screen

Effective June 30, 2016, the P status for fee item P92151 – PPCD screen was removed.

LSA2016-009

Removal of Provisional (P) status for seven antinuclear antibody (ANA) tests, and amendment to billing notes, to allow for provincial wide use of the ANA tests

Effective June 30, 2016, the P status was removed for the following seven fee items:

P90280 Antinuclear antibodies – immunofluorescence screen

P90281 Antinuclear antibodies by sensitive EIA

P90120 Extractable nuclear antigens (ENA)

P90121 Antinuclear antibodies, specific detection by multiplex immunoassay

P90286 Liver autoantibodies (LiAA), immunofluorescence

P90287 Anti-neutrophil cytoplasmic antibodies (ANCA), immunofluorescence screen

P90288 Anti-parietal cell antibody (APCA), immunofluorescence screen

For fee items 90121 and 90281, note ii) was removed, that read

“Restricted to Vancouver Coastal Health Immunology Laboratory”, and replaced with the following

Use ANA/ENA ELISA (90281) as the primary screen; if result of ANA/ENA ELISA (90281) is ≥2U (units), proceed with reflex testing using ENA/DNA multiplex (90121)”

For fee item 90286, the following note was added:

Only one of either 90286 or 90288, not both, are payable for the same sample tested on the same day”

For fee item 90288, note i) was removed, that read

“P90288 (APCA) is not payable with P90286 (LiAA), and was replaced with the following

Only one of either 90286 or 90288, not both, are payable for the same sample tested on the same day”

LSA2016-010

Delist fee item 91210 aspartate aminotransferase (AST)

Effective February 1, 2017, fee item 91210 aspartate aminotransferase (AST) will be delisted. Laboratory operators are to substitute any request for AST with fee item 91065 alanine aminotransferase (ALT)

LSA2016-013

Re-Costing of test 91745 Hemoglobin, A1C, and amendments to billing note

Effective October 1, 2016, the amount for fee item 91745 Hemoglobin, A1C will be changed to $5.30 from $12.69.

Fee item 91745 Hemoglobin A1C will be eligible to be co-billed with the primary base fee (PBF), 91000 or the split base fees 91005 and 91010. Base fees note iv) will be updated in the Laboratory Services Outpatient Payment Schedule to include fee item 91745.

 

2016 - Laboratory & Specimen Collection Station Approvals

Laboratory Facilities Records of Decision under the Laboratory Services Act

LSA ROD #

Approvals Granted

LSA2017-004

Interior Health Authority - North Hills Mall Primary Care Home

61 - 700 Tranquille Road, Kamloops, BC

Approved new specimen collection station

LSA2016-028

LifeLabs

566 Artisan Lane, Bowen Island, BC

Approved new specimen collection station.

LSA2016-029

Northern Health Authority – Hudson’s Hope Gething Diagnostic and Treatment Centre

10309 Kyllo Street, Hudson’s Hope, BC

Approved to amend Laboratory Facility Approval to include fee item 90440 (prothrombin time/INR).

LSA2016-030

Vancouver Island Health Authority – Royal Jubilee Hospital

23 Helmcken Road, Victoria, BC

Approved to relocate offsite specimen collection station to 23 Helmcken Road, Victoria, BC, from 1505 Admirals Road, Victoria, BC.

LSA2016-032

LifeLabs

103 – 495 Bowen Island Trunk Road, Bowen Island, BC

Approved to relocate specimen collection station to 103 - 495 Bowen Island Trunk Road, Bowen Island, BC, from 101 – 469 Bowen Island Trunk Road, Bowen Island, BC.

LSA2016-033

LifeLabs

1001 Hudson Avenue, Richmond, BC

Approved new specimen collection station at the Pacific Autism Family Centre.

LSA2016-014

Vancouver Island Health Authority – Comox Valley Hospital

101 Lerwick Road, Comox, BC

Approved new onsite laboratory facility and specimen collection station. Laboratory services include fee-for-service category 2M, plus microbiology fee items: 90800, 90805, and 90810.

LSA2016-016

Vancouver Island Health Authority – St. Joseph's General Hospital

2137 Comox Valley Avenue, Comox, BC

Approved - Amendment to the Laboratory  to provide offsite specimen collection services for Comox Valley Hospital.

LSA2016-017

Vancouver Island Health Authority - Comox Valley Hospital

307 – 14th Street, Courtenay, BC

Approved to provide offsite specimen collection services.

LSA2016-023

Interior Health Authority – Tudor Village 

205 – 1150 Hillside Drive, Kamloops, BC

Approved to relocate their specimen collection station to 205 – 1150 Hillside Drive, Kamloops, BC, from 3 – 1315 Summit Drive, Kamloops, BC.

LSA2016-025

Novavita Laboratory

Suite 420, East Tower, 555 W 12th Avenue, Vancouver, BC

Denied moratorium exemption request for a new specimen collection station.

LSA2016-001

Valley Medical Laboratories

114 - 1835 Gordon Drive, Kelowna, BC

Approved to relocate specimen collection station from 1111 Springfield Road, Kelowna, BC, to 114 - 1835 Gordon Drive, Kelowna, BC.  

LSA2016-002

Vancouver Coastal Health Authority – Whistler Health Care Centre

4380 Lorimer Rd, Whistler, BC

Approved to amend the laboratory facility approval to include Category 2A (Haematology) and 2C (Chemistry).

LSA2016-003

Vancouver Coastal Health Authority – Pemberton Health Centre

1403 Portage Rd, Pemberton, BC

Approved to amend the laboratory facility approval to include 12 fee-for-service tests, and the replacement of amylase with lipase.

LSA2016-004

LifeLabs 

230 – 1900 Richmond Road, Victoria, BC

Approved for the temporary relocation of specimen collection station from Suite 130 – 1900 Richmond Road, Victoria, BC, to 230 – 1900 Richmond Road, Victoria, BC.

LSA2016-005

LifeLabs

7455 – 130th Street, Surrey, BC

Approved to amend the Laboratory Facility Approval to include the following three hematology fee-for-service tests: Factor V Leiden/PGM – 1st Gene; Factor V Leiden/PGM – 2nd Gene; and HLA Single Antigen.

LSA2016-011

LifeLabs

2680 Gilmore Way, Burnaby, BC

Approved to increase chemistry capacity and hematology capacity. Surrey Reference Laboratory approval is amended to remove Chemistry and Hematology.

 

2015 - Laboratory & Specimen Collection Station Approvals

Laboratory Facilities Records of Decision under the Laboratory Services Act

LSA ROD #

Approvals Granted

LSA2015-009

LifeLabs –Reference Laboratory

7455 130th Street, Surrey, BC

Approved for temporary relocation of microbiology testing from Burnaby Reference Laboratory to the mobile testing unit at Surrey Reference Laboratory.

Contact Us

Share Button